In compliance with section 1847A(i)(1)(B) of the Act, manufacturers of a Part B rebatable drug must provide a rebate for each Part B rebatable drug no later than 30 calendar days after the receipt of the information provided by the Secretary in section 1847A(i)(1)(A) of the Act
They are not intended to diagnose, treat, cure, or prevent any disease
BPC 157-rats Specifically, BPC 157, 10 g/kg, 10 ng/kg regimens, exhibited a consistent counteracting effect (i.e., markedly reduced the bleeding time, blood loss and also counteracted: acute thrombocytopenia in rats with amputation only, in heparin-rats or warfarin-rats), prolonged APTT-, TT- values (heparin-rats), but not PT-values (warfarin-rats))
The authors even went so far as to call this action resetting genes to promote normal functioning
10.3390/molecules21030356 Summary Keywords alopecia, cacumen platycladi, hair follicles, dermal papilla cells, Akt, GSK3 Citation Fu H, Li W, Weng Z, Huang Z, Liu J, Mao Q and Ding B (2023) Water extract of cacumen platycladi promotes hair growth through the Akt/GSK3/-catenin signaling pathway
Some individuals may experience mild soreness at the injection site or temporary side effects like headache or nausea